Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Neural encoding of psychomotor activation in the nucleus accumbens core, but not the shell, requires cannabinoid receptor signaling.

Morra JT, Glick SD, Cheer JF.

J Neurosci. 2010 Apr 7;30(14):5102-7. doi: 10.1523/JNEUROSCI.5335-09.2010.

2.

Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.

Morra JT, Glick SD, Cheer JF.

Neuropharmacology. 2012 Sep;63(4):565-74. doi: 10.1016/j.neuropharm.2012.04.036. Epub 2012 May 15.

3.

Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.

Loewinger GC, Beckert MV, Tejeda HA, Cheer JF.

Neuropharmacology. 2012 Jun;62(7):2192-201. doi: 10.1016/j.neuropharm.2012.01.013. Epub 2012 Jan 25.

4.

Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration.

Rodriguez JS, Boctor SY, Flores LC, Phelix CF, Martinez JL Jr.

Neurosci Lett. 2011 Feb 11;489(3):187-91. doi: 10.1016/j.neulet.2010.12.013. Epub 2010 Dec 15.

5.

Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation.

Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM.

J Neurosci. 2007 Jan 24;27(4):791-5.

6.

Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling.

Kodas E, Cohen C, Louis C, Griebel G.

Psychopharmacology (Berl). 2007 Oct;194(2):161-71. Epub 2007 Jun 8.

PMID:
17557151
7.

Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats.

Khodayar E, Oryan S, Nasehi M, Zarrindast MR.

Behav Pharmacol. 2016 Feb;27(1):12-21. doi: 10.1097/FBP.0000000000000174.

PMID:
26340366
8.

Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system.

Perra S, Pillolla G, Luchicchi A, Pistis M.

Alcohol Clin Exp Res. 2008 Mar;32(3):443-9. doi: 10.1111/j.1530-0277.2007.00588.x. Epub 2008 Jan 22.

PMID:
18215217
9.

Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats.

Azizi P, Haghparast A, Hassanpour-Ezatti M.

Behav Brain Res. 2009 Jan 30;197(1):119-24. doi: 10.1016/j.bbr.2008.08.009. Epub 2008 Aug 19.

PMID:
18773925
10.

Involvement of the nucleus accumbens shell glutamatergic system in ACPA-induced impairment of inhibitory avoidance memory consolidation.

Rasekhi K, Oryan S, Nasehi M, Zarrindast MR.

Behav Brain Res. 2014 Aug 1;269:28-36. doi: 10.1016/j.bbr.2014.04.006. Epub 2014 Apr 13.

PMID:
24739359
11.

Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.

Schoffelmeer AN, Hogenboom F, Wardeh G, De Vries TJ.

Neuropharmacology. 2006 Sep;51(4):773-81. Epub 2006 Jun 30.

PMID:
16806307
12.
13.

Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.

Deshmukh RR, Sharma PL.

Pharmacol Res. 2012 Sep;66(3):276-82. doi: 10.1016/j.phrs.2012.06.004. Epub 2012 Jun 21.

PMID:
22728691
14.

Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.

Ramiro-Fuentes S, Fernandez-Espejo E.

Psychopharmacology (Berl). 2011 Apr;214(4):949-59. doi: 10.1007/s00213-010-2104-4. Epub 2010 Dec 3. Erratum in: Psychopharmacology (Berl). 2012 Aug;222(3):547.

PMID:
21128069
15.

Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.

Ramiro-Fuentes S, Ortiz O, Moratalla R, Fernandez-Espejo E.

Neuroscience. 2010 May 5;167(2):205-15. doi: 10.1016/j.neuroscience.2010.02.019. Epub 2010 Feb 16.

PMID:
20167255
16.

A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.

Eisenstein SA, Clapper JR, Holmes PV, Piomelli D, Hohmann AG.

Pharmacol Res. 2010 May;61(5):419-29. doi: 10.1016/j.phrs.2009.12.013. Epub 2010 Jan 5.

17.

Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.

Mendiguren A, Pineda J.

Br J Pharmacol. 2009 Nov;158(6):1579-87. doi: 10.1111/j.1476-5381.2009.00434.x. Epub 2009 Oct 20.

18.

The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.

Thiemann G, Di Marzo V, Molleman A, Hasenöhrl RU.

Pharmacol Biochem Behav. 2008 May;89(3):384-91. doi: 10.1016/j.pbb.2008.01.010. Epub 2008 Jan 26.

PMID:
18294680
19.

Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.

Hernandez G, Cheer JF.

J Neurosci. 2012 Aug 15;32(33):11467-77. doi: 10.1523/JNEUROSCI.1833-12.2012.

20.

Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.

De Oliveira Alvares L, Genro BP, Diehl F, Quillfeldt JA.

Neurobiol Learn Mem. 2008 Jul;90(1):1-9. doi: 10.1016/j.nlm.2008.01.009. Epub 2008 Mar 14.

PMID:
18342551

Supplemental Content

Support Center